Stocks股票 / Health Care / PRGO
PRGO US listed · USD美股 · 美元
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of...Perrigo Company plc 是一家美国公司在爱尔兰注册的制造商,生产自有品牌非处方药。尽管Perrigo 70%的净销售额来自美国医疗体系,但其出于税务目的合法将总部设在爱尔兰,该地仅占净销售额的0.60%。
Price chart价格图表
Technicals技术面
daily bars日线数据 · 2026-07-21Earnings财务业绩
next report下次财报 2026-08-05Estimates being cut预期下调
Valuation估值
Looks cheap vs sector相对行业偏便宜| Multiple指标 | PRGO | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/B市净率 | 0.50x | 3.44 | |
| P/S市销率 | 0.34x | 2.97 | |
| Earnings yield盈利收益率 | -97.82% | 2.72 | |
| FCF yield自由现金流收益率 | 9.96% | 4.00 | |
| P/FCF市值/自由现金流 | 10.04x | 22.08 |
Financials财务数据
fiscal years财年Leverage杠杆
Capital allocation资本配置
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向: +$0.1M net (1 buyers, 0 sellers)+$0.1M 净值(1 买家,0 卖家)
Signal history信号历史
engine events引擎事件Company profile公司档案
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of...Perrigo Company plc 是一家美国公司在爱尔兰注册的制造商,生产自有品牌非处方药。尽管Perrigo 70%的净销售额来自美国医疗体系,但其出于税务目的合法将总部设在爱尔兰,该地仅占净销售额的0.60%。
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Valuation vs sector估值对比行业
| Multiple指标 | This stock本股 | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| Price / Book市净率 | 0.5× | 3.4× | 99% |
| Price / Sales市销率 | 0.3× | 3.0× | 95% |
| Earnings yield盈利收益率 | -97.8% | 2.7% | 1% |
| Free-cash-flow yield自由现金流收益率 | 16.4% | 5.5% | 95% |
Relative strength相对强度
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | +4.1% | -0.9% |
| 1 Month近1月 | +3.3% | -0.6% |
| 3 Months近3月 | -7.4% | +5.4% |
| 6 Months近6月 | -25.5% | +8.6% |
| Year to date年初至今 | -20.0% | +8.9% |
| 1 Year近1年 | -58.3% | +19.2% |
| 3 Years近3年 | -65.7% | +69.9% |
Trading information交易信息
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $5.1B | $4.1B | $4.5B | $4.7B | $4.4B | $4.3B |
| EPS每股收益 | $-1.19 | $-0.52 | $-1.04 | $-0.09 | $-1.25 | $-10.29 |
| Free cash flow自由现金流 | $466M | $4M | $211M | $304M | $245M | $145M |
| Gross margin毛利率 | 35.9% | 34.2% | 32.7% | 36.1% | 35.3% | 35.1% |
| Net margin净利率 | -3.2% | -1.7% | -3.2% | -0.3% | -3.9% | -33.5% |
| FCF margin自由现金流利润率 | 9.2% | 0.1% | 4.7% | 6.5% | 5.6% | 3.4% |
Latest fiscal year最近财年
Returns & growth回报与增长
Accounting quality checks会计质量检查
- Earnings quality: earnings cash-backed盈利质量:盈利有现金支撑
- Working capital: working capital roughly in line with sales营运资本:营运资本与销售大致同步
- Pricing power: soft gross profitability vs peers定价能力:毛利能力弱于同业
- Capital discipline: disciplined growth, returning cash资本纪律:增长克制、回报股东
- Balance sheet: Altman Z -0.13 — distress zone资产负债表:Altman Z -0.13——困境区
Indicator readings指标读数
Timeframe alignment多周期共振
Volatility regime波动状态
Estimate revisions预期修正
Insiders & shorts内部人与空头
Month by month逐月统计
| Month月份 | Closed higher收涨占比 | Median move中位涨跌 | Years年数 |
|---|---|---|---|
| Jan1月 | 33% | -0.2% | 3 |
| Feb2月 | 33% | -6.7% | 3 |
| Mar3月 | 33% | -2.1% | 3 |
| Apr4月 | 67% | +1.8% | 3 |
| May5月 | 33% | -3.5% | 3 |
| Jun6月 | 25% | -1.3% | 4 |
| Jul7月 | 100% | +7.8% | 4 |
| Aug8月 | 33% | -3.3% | 3 |
| Sep9月 | 0% | -8.9% | 3 |
| Oct10月 | 0% | -6.9% | 3 |
| Nov11月 | 67% | +11.2% | 3 |
| Dec12月 | 67% | +4.6% | 3 |